• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

'We're open for business': FDA's Peter Marks says agency ready to...

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Apr 03, 2024 at 10:42: PM
via As new cancer vaccines—led by Moderna and Merck’s mRNA-4157—near pivotal trial readouts, the FDA’s vaccines czar Peter Marks, M.D., Ph.D., said the agency is ready to review the shots despite AI-related unknowns.

article source
 

<



Similar threads

cafead
Astellas to Open New Life Sciences Facility in DivcoWest&#039;s Cambridge Crossing Neighborhood
Replies
0
Views
196
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Biogen Alzheimer&#039;s approval could open the door for other similar drugs
Replies
0
Views
103
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
After $600M sales hit from pandemic, Merck&#039;s open to &#039;all forms&#039; of M&amp;A...
Replies
0
Views
122
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Merck&#039;s Keytruda Plus Eisai&#039;s Lenvima Could Open New Standard of Care in Renal Cancer
Replies
0
Views
112
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Roche cracks China&#039;s ADC market open as Kadcyla scores its first breast cancer OK in...
Replies
0
Views
112
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote